GB2490671B - Dosage Unit for Administration of Antibiotics to the Small and Large Intestine - Google Patents

Dosage Unit for Administration of Antibiotics to the Small and Large Intestine

Info

Publication number
GB2490671B
GB2490671B GB1107652.8A GB201107652A GB2490671B GB 2490671 B GB2490671 B GB 2490671B GB 201107652 A GB201107652 A GB 201107652A GB 2490671 B GB2490671 B GB 2490671B
Authority
GB
United Kingdom
Prior art keywords
antibiotics
administration
small
dosage unit
large intestine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB1107652.8A
Other versions
GB2490671A (en
GB201107652D0 (en
Inventor
Brown Stephen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MW Encap Ltd
Original Assignee
MW Encap Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MW Encap Ltd filed Critical MW Encap Ltd
Priority to GB1107652.8A priority Critical patent/GB2490671B/en
Publication of GB201107652D0 publication Critical patent/GB201107652D0/en
Publication of GB2490671A publication Critical patent/GB2490671A/en
Application granted granted Critical
Publication of GB2490671B publication Critical patent/GB2490671B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB1107652.8A 2011-05-09 2011-05-09 Dosage Unit for Administration of Antibiotics to the Small and Large Intestine Expired - Fee Related GB2490671B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1107652.8A GB2490671B (en) 2011-05-09 2011-05-09 Dosage Unit for Administration of Antibiotics to the Small and Large Intestine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1107652.8A GB2490671B (en) 2011-05-09 2011-05-09 Dosage Unit for Administration of Antibiotics to the Small and Large Intestine

Publications (3)

Publication Number Publication Date
GB201107652D0 GB201107652D0 (en) 2011-06-22
GB2490671A GB2490671A (en) 2012-11-14
GB2490671B true GB2490671B (en) 2017-12-20

Family

ID=44243776

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1107652.8A Expired - Fee Related GB2490671B (en) 2011-05-09 2011-05-09 Dosage Unit for Administration of Antibiotics to the Small and Large Intestine

Country Status (1)

Country Link
GB (1) GB2490671B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104302278B (en) 2012-03-29 2018-08-21 塞拉拜姆有限责任公司 The active stomach and intestine locus specificity Oral vaccination preparation on ileum and appendix
EP2968187A4 (en) 2013-03-14 2016-08-17 Therabiome Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1020177A1 (en) * 1997-09-10 2000-07-19 Morishita Jintan Co., Ltd. Multilayered soft capsule for eliminating foul breath and process for producing the same
WO2003072088A1 (en) * 2002-02-26 2003-09-04 Natalie Herbon Capsule for the time-delayed dispensing of nutrients and/or active substances
US20050008690A1 (en) * 2002-04-10 2005-01-13 Miller Fred H. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1020177A1 (en) * 1997-09-10 2000-07-19 Morishita Jintan Co., Ltd. Multilayered soft capsule for eliminating foul breath and process for producing the same
WO2003072088A1 (en) * 2002-02-26 2003-09-04 Natalie Herbon Capsule for the time-delayed dispensing of nutrients and/or active substances
US20050008690A1 (en) * 2002-04-10 2005-01-13 Miller Fred H. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same

Also Published As

Publication number Publication date
GB2490671A (en) 2012-11-14
GB201107652D0 (en) 2011-06-22

Similar Documents

Publication Publication Date Title
IL265707A (en) Pharmaceutical compositions comprising human antibodies to pcsk9
HK1205690A1 (en) Pharmaceutical composition and administration thereof
HK1208801A1 (en) Orally administered medical composition
EP2526986A4 (en) Medicine administering device
EP2726066A4 (en) Dosage forms for oral administration and methods of treatment using the same
IL228441A0 (en) Controlled release pharmaceutical dosage forms
PL3415139T3 (en) Administration of benzodiazepine
EP2718283A4 (en) Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
HK1206292A1 (en) Medicament administration
ZA201306395B (en) New low side effect pharmaceutical composition containing antituberculosis drugs
AP2015008208A0 (en) Pharmaceutical administration forms comprising
ZA201502695B (en) Stable pharmaceutical composition of peginterferon alpha-2b
GB2490671B (en) Dosage Unit for Administration of Antibiotics to the Small and Large Intestine
IL227651A0 (en) Pharmaceutical formulation for topical administration comprising b220
EP2887882A4 (en) Isolation of lymphocytes and delivery to splenectomy patients
ZA201201424B (en) Pharmaceutical dosage form
HK1200101A1 (en) Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them
RS59133B1 (en) Dosage forms for oral administration of active substances
GB201112578D0 (en) Pharmaceutical preparation and use
GB201112739D0 (en) Production and administration of therapeutic agents
GB201104632D0 (en) Use of medicament
PT3326648T (en) Pharmaceutical compositions comprising human antibodies to pcsk9
HUP1000284A3 (en) Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20190509